Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Hartung

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
JAMA Internal Medicine|December 13, 2021
Characterization of the Clinical Evidence Supporting Repository Corticotropin Injection for FDA-Approved Indications: A Scoping ReviewKim A Tran, Curtis Harrod, Dennis N Bourdette, et al.
Pain|April 17, 2021
Patient outcomes after opioid dose reduction among patients with chronic opioid therapySara E Hallvik, Sanae El Ibrahimi, Kirbee Johnston, et al.
Research in Social & Administrative Pharmacy : RSAP|January 19, 2020
Development and pilot of a prescription drug monitoring program and communication intervention for pharmacistsLindsey Alley, Kevin Novak, Tyler Havlin, et al.
American Journal of Preventive Medicine|October 18, 2024
Chronic Opioid Use After Implementation of Oregon's Medicaid Back Pain PolicyDaniel M Hartung, Sanae El Ibrahimi, Catherine J Livingston, et al.
Drug and Alcohol Dependence Reports|August 7, 2024
Association of economic and racial segregation with restricted buprenorphine dispensing in U.S. community pharmaciesKyle J Moon, Sabriya L Linton, Neda J Kazerouni, et al.
Archives of General Psychiatry|January 6, 2010
Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugsElaine H Morrato, Benjamin Druss, Daniel M Hartung, et al.
Pain Medicine (Malden, Mass.)|October 11, 2017
Pharmacists' Role in Opioid Safety: A Focus Group InvestigationDaniel M Hartung, Jennifer Hall, Sarah N Haverly, et al.
Medical Care|June 4, 2008
Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid populationDaniel M Hartung, Matthew J Carlson, Dale F Kraemer, et al.
American Journal of Infection Control|February 25, 2012
Risk factors associated with linezolid-nonsusceptible enterococcal infectionsJessina C McGregor, Daniel M Hartung, George P Allen, et al.
BMC Health Services Research|January 15, 2022
Evaluation of a Medicaid performance improvement project to reduce high-dose opioid prescriptionsDaniel M Hartung, Jonah Geddes, Sara E Hallvik, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
JAMA Internal Medicine|December 13, 2021
Characterization of the Clinical Evidence Supporting Repository Corticotropin Injection for FDA-Approved Indications: A Scoping ReviewKim A Tran, Curtis Harrod, Dennis N Bourdette, et al.
Pain|April 17, 2021
Patient outcomes after opioid dose reduction among patients with chronic opioid therapySara E Hallvik, Sanae El Ibrahimi, Kirbee Johnston, et al.
Research in Social & Administrative Pharmacy : RSAP|January 19, 2020
Development and pilot of a prescription drug monitoring program and communication intervention for pharmacistsLindsey Alley, Kevin Novak, Tyler Havlin, et al.
American Journal of Preventive Medicine|October 18, 2024
Chronic Opioid Use After Implementation of Oregon's Medicaid Back Pain PolicyDaniel M Hartung, Sanae El Ibrahimi, Catherine J Livingston, et al.
Drug and Alcohol Dependence Reports|August 7, 2024
Association of economic and racial segregation with restricted buprenorphine dispensing in U.S. community pharmaciesKyle J Moon, Sabriya L Linton, Neda J Kazerouni, et al.
Archives of General Psychiatry|January 6, 2010
Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugsElaine H Morrato, Benjamin Druss, Daniel M Hartung, et al.
Pain Medicine (Malden, Mass.)|October 11, 2017
Pharmacists' Role in Opioid Safety: A Focus Group InvestigationDaniel M Hartung, Jennifer Hall, Sarah N Haverly, et al.
Medical Care|June 4, 2008
Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid populationDaniel M Hartung, Matthew J Carlson, Dale F Kraemer, et al.
American Journal of Infection Control|February 25, 2012
Risk factors associated with linezolid-nonsusceptible enterococcal infectionsJessina C McGregor, Daniel M Hartung, George P Allen, et al.
BMC Health Services Research|January 15, 2022
Evaluation of a Medicaid performance improvement project to reduce high-dose opioid prescriptionsDaniel M Hartung, Jonah Geddes, Sara E Hallvik, et al.
Pageof 11